KNSA: Kiniksa Pharmaceuticals Ltd - Class A
KNSA exchange rate has changed by -3.18% for today. During the day, the instrument was traded at a low of 77.90 and at a high of 80.43.
Follow Kiniksa Pharmaceuticals Ltd - Class A dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KNSA News
- TGTX Stock Outperforms 95% of Stocks. Here's Why.
- Three Biotech Stocks Stick Out With Their Stellar Charts
- Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan
- KNSA Q2 Earnings Call Backs Higher ARCALYST Sales Outlook
- Kiniksa Pharmaceuticals International, plc 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KNSA) 2026-07-31
- Stock Market Rises Amid Apple, Amazon, Meta, Microsoft Earnings, Soaring Yields: Weekly Review
- MDGL Stock Down Despite Q2 Beat, MASH Drug Drives Top-Line Y/Y Growth
- Teva Q2 Earnings Lag Estimates, 2026 Revenue View Raised, Stock Rises
- Earnings Estimates Rising for Kiniksa Pharmaceuticals International, plc (KNSA): Will It Gain?
- Alkermes Q2 Earnings Break Even, Revenues Beat Estimates, Stock Down
- Kiniksa Pharmaceuticals International, plc (KNSA) Q2 Earnings Match Estimates
- EU Clears AZN's Etcamah Combo for First-Line ER-Positive Breast Cancer
- Zacks.com featured highlights include American Outdoor Brands, Cimpress, National Energy Services Reunited, CTO Realty Growth and Kiniksa Pharmaceuticals International
- PFE's Talzenna sNDA Gets FDA Priority Tag in Wider Prostate Cancer Use
- Community Health Q2 Loss Wider Than Expected, 2026 View Lowered
- Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
- 5 Stocks With Recent Price Strength Despite Recent Market Volatility
- NKTR Up on Start of Phase III Program on Rezpeg for Atopic Dermatitis
- Recent Price Trend in Kiniksa Pharmaceuticals International, plc (KNSA) is Your Friend, Here's Why
- Profitable Biotechs Strut Their Stuff As Stock Market Stumbles
- Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout
- UnitedHealth Tops Q2 Earnings on Cost Control, Raises '26 Outlook
- ATAI Stock Soars on Reports of Potential Acquisition by Eli Lilly
- AZN Inks Deal With Dizal to In-License Rights to Lung Cancer Drug
Frequently Asked Questions
What is KNSA stock price today?
Kiniksa Pharmaceuticals Ltd - Class A stock is priced at 77.91 today. It trades within 77.90 - 80.43, yesterday's close was 80.47, and trading volume reached 964. The live price chart of KNSA shows these updates.
Does Kiniksa Pharmaceuticals Ltd - Class A stock pay dividends?
Kiniksa Pharmaceuticals Ltd - Class A is currently valued at 77.91. Dividend policy depends on the company, while investors also watch 96.52% and USD. View the chart live to track KNSA movements.
How to buy KNSA stock?
You can buy Kiniksa Pharmaceuticals Ltd - Class A shares at the current price of 77.91. Orders are usually placed near 77.91 or 78.21, while 964 and -2.33% show market activity. Follow KNSA updates on the live chart today.
How to invest into KNSA stock?
Investing in Kiniksa Pharmaceuticals Ltd - Class A involves considering the yearly range 35.20 - 82.94 and current price 77.91. Many compare -0.49% and 59.49% before placing orders at 77.91 or 78.21. Explore the KNSA price chart live with daily changes.
What are Kiniksa Pharmaceuticals Ltd - Class A stock highest prices?
The highest price of Kiniksa Pharmaceuticals Ltd - Class A in the past year was 82.94. Within 35.20 - 82.94, the stock fluctuated notably, and comparing with 80.47 helps spot resistance levels. Track Kiniksa Pharmaceuticals Ltd - Class A performance using the live chart.
What are Kiniksa Pharmaceuticals Ltd - Class A stock lowest prices?
The lowest price of Kiniksa Pharmaceuticals Ltd - Class A (KNSA) over the year was 35.20. Comparing it with the current 77.91 and 35.20 - 82.94 shows potential long-term entry points. Watch KNSA moves on the chart live for more details.
When did KNSA stock split?
Kiniksa Pharmaceuticals Ltd - Class A has gone through stock splits historically. These changes are visible in , 80.47, and 96.52% after corporate actions.
- Previous Close
- 80.47
- Open
- 79.77
- Bid
- 77.91
- Ask
- 78.21
- Low
- 77.90
- High
- 80.43
- Volume
- 964
- Daily Change
- -3.18%
- Month Change
- -0.49%
- 6 Months Change
- 59.49%
- Year Change
- 96.52%